The "Wall Street Trading Letter" is published weekly using the unique cycle analysis created by its editor and publisher, Peter Bruno. Mr. Bruno updates each issue by 11:00 a.m. Monday morning. The information contained herein is derived from the original or published sources believed reliable, but its completeness and accuracy - and that of the opinions based thereon - is not guaranteed. Opinions expressed along with recommendations are subject to change without notice.
The "Wall Street Trading Letter", its employees, clients or family members from time to time, have a position in the securities mentioned. There is no guarantee that the "Wall Street Trading Letter"recommendations will be profitable in the future or that they will equal the performance of any previous recommendations. No assignment of subscription shall be made without the subscriber's approval. Any reproduction or duplication of this material in any form without prior written permission from the Wall Street Money Letter, Inc. is strictly forbidden.
The "Wall Street Trading Letter" combines various trading strategies divided for specific styles of trading. Our most aggressive strategy, which has in the past generated the highest and quickest trading profits, is our Bruno Oscillator Strategy.
The Bruno Oscillator Trading Strategy is not a trading strategy for the faint of heart. It consists of cycles that are a combination of indicators forming an aggressive shorter term cycle incorporated within a three system cycle oscillator identifying overbought and oversold investment price criteria. In most cases, if not all, buy and sell decisions suggested in this newsletter in other categories would not only be counter to our cycle recommendations offered, but would also violate the basic tenants of investing. Buying when everyone is selling and selling when everyone is buying is certainly a contrarian's trading strategy and decision, but the objective of trading is to make money and with high risk also comes high rewards. What is important in trading is buying at the right price and more importantly, profiting by selling at the right moment.
The Biotech Index of stocks, for many years has led the stock market up as well as down.. Major Biotech stocks have consistent earnings and revenue streams and are also higher priced. Baby biotech securities are usually performing "clinical trials" in an attempt to seek approval from the Federal Drug Administration and can be very profitable if successful or experience potential bankruptcy if not. Although we believe our cycle analysis, in most part, can anticipate good fundamental news, there is no guarantee. Subscribers should also be aware that since most of these Biotechnology stocks are traded on NASDAQ, some issues may have a wider spread between their Bid and Ask price and only Limit Orders should be placed when buying or selling to avoid execution price surprises.
This service is designed for the more AGGRESSIVE TRADER who understands that greater rewards often walk hand in hand with greater risk. Purchase recommendations are the result of one key indicator in our stable of indicators that has signaled a short term trade within the volatile area of ETFs which include some issues that can trade three times the up or down move of the underlining index.
One key concept to understand in short term trading is that our Short Term Early Warning Cycle can last for as little as three days and can move up or down regardless of the directional movement of our longer term cycles. This "Early Warning Cycle is ideal for day trading or establishing or ending a position. Inverse ETF's, which move up when indices move down, can also be used to hedge long positions in other portfolios remembering that markets move up in a stair step and down as in an elevator.